Gabelli Funds’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-540,240
Closed -$52.4M – 1165
2019
Q3
$52.4M Sell
540,240
-82,227
-13% -$8.23M 0.35% 68
2019
Q2
$63.7M Buy
622,467
+30,329
+5% +$3.27M 0.41% 59
2019
Q1
$67.4M Buy
+592,138
New +$43.5M 0.42% 48

Gabelli Funds's ONCE Position: Q4 2019 in Review

Gabelli Funds sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 540,240 shares — an estimated $52.4M sold.

Gabelli Funds first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $67.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Gabelli Funds reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Gabelli Funds sold 540,240 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $52.4M.
  • Gabelli Funds first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Gabelli Funds's Spark Therapeutics, Inc. Common Stock position peaked at $67.4M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.